DrugBank Biotech Products
Baxter 2005 AR
RNAi-Mediated Inhibition of a Natural Anticoagulant for the Treatment of Hemophilia OTS 2012—Session VI: RNAi/ASO Preclinical Studies Akin Akinc, PhD October.
Therapeutics for Hemophilia A – Where we are, how we got there and where I think we are going * Roger L. Lundblad, Ph.D. Consultant in Biotechnology Chapel.
pdf-1147
Therapeutics for Hemophilia A – Where we are, how we got there and where I think we are going *
WHO Norms and Standards: Blood Products & related Biologicals Dr Ana Padilla Blood Products & related Biologicals WHO/HIS/EMP/RHT.
